Patterns of antithrombotic therapy and type of atrial fibrillation: insights from the Global Anticoagulant Registry in the FIELD (GARFIELD)

被引:0
|
作者
Lip, G. Y. H. [1 ]
Rushton-Smith, S. K. [2 ]
Goto, S. [3 ]
Verheugt, F. W. A. [4 ]
Goldhaber, S. Z. [5 ]
Haas, S. [6 ]
Bassand, J. P. [7 ]
Mueller, I. [2 ]
Kakkar, A. K. [2 ]
机构
[1] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England
[2] Thrombosis Res Inst, London SW3 6LR, England
[3] Tokai Univ, Dept Med, Hiratsuka, Kanagawa 25912, Japan
[4] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[6] Tech Univ Munich, Munich, Germany
[7] Univ Hosp Jean Minjoz, Besancon, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:54 / 54
页数:1
相关论文
共 50 条
  • [1] Regional differences in the use of antithrombotic therapy for stroke prevention in atrial fibrillation: European and Asian insights from the Global Anticoagulant Registry in the FIELD (GARFIELD)
    Goto, S.
    Mueller, I.
    Fitzmaurice, D. A.
    Haas, S.
    Lip, G. Y. H.
    Turpie, A. G. G.
    Goldhaber, S. Z.
    Rushton-Smith, S.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 685 - 685
  • [2] Antithrombotic Treatments and Associated Outcomes in Patients with Atrial Fibrillation: The Global Anticoagulant Registry in the FIELD (GARFIELD)
    Kakkar, Ajay K.
    CIRCULATION, 2012, 126 (23) : 2792 - 2793
  • [3] Gender differences in use of antithrombotic therapy in atrial fibrillation: real-world perspective from the Global Anticoagulant Registry in the FIELD (GARFIELD)
    Lip, G. Y. H.
    Rushton-Smith, S. K.
    Goldhaber, S. Z.
    Fitzmaurice, D. A.
    Mantovani, L. G.
    Goto, S.
    Haas, S.
    Bassand, J. P.
    Mueller, I.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 58 - 58
  • [4] Antithrombotic treatment patterns for stroke prevention in relation to age: insights from the Global Anticoagulant Registry in the FIELD (GARFIELD)
    Bassand, J. P.
    Mueller, I.
    Mantovani, L. G.
    Haas, S.
    Goldhaber, S. Z.
    Goto, S.
    Lip, G. Y. H.
    Rushton-Smith, S. K.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 52 - 53
  • [5] The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)
    ten Cate, V.
    ten Cate, H.
    Verheugt, F. W. A.
    NETHERLANDS HEART JOURNAL, 2016, 24 (10) : 574 - 579
  • [6] INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY
    Lip, Gregory
    Bassand, Jean-Pierre
    Fitzmaurice, David
    Goldhaber, Samuel
    Goto, Shinya
    Verheugt, Freek
    Turpie, Alexander
    Mueller, Iris
    Rushton-Smith, Sophie
    Kakkar, Ajay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E670 - E670
  • [7] Antithrombotic therapy for stroke prevention in patients with newly diagnosed atrial fibrillation and a history of acute coronary syndrome: the Global Anticoagulant Registry in the FIELD (GARFIELD)
    Verheugt, F. W. A.
    Bassand, J. P.
    Turpie, A. G. G.
    Fitzmaurice, D. A.
    Haas, S.
    Goto, S.
    Lip, G. Y. H.
    Mueller, I.
    Rushton-Smith, S. K.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1081 - 1081
  • [8] International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)
    Kakkar, Ajay K.
    Mueller, Iris
    Bassand, Jean-Pierre
    Fitzmaurice, David A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Haas, Sylvia
    Hacke, Werner
    Lip, Gregory Y. H.
    Mantovani, Lorenzo G.
    Verheugt, Freek W. A.
    Jamal, Waheed
    Misselwitz, Frank
    Rushton-Smith, Sophie
    Turpie, Alexander G. G.
    AMERICAN HEART JOURNAL, 2012, 163 (01) : 13 - U31
  • [9] Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)
    Fox, Keith A. A.
    Accetta, Gabriele
    Pieper, Karen S.
    Bassand, Jean-Pierre
    Camm, A. John
    Fitzmaurice, David A.
    Kayani, Gloria
    Kakkar, Ajay K.
    Lucas Luciardi, Hector
    Gibbs, Harry
    Brodmann, Marianne
    Cools, Frank
    Pereira Barretto, Antonio Carlos
    Connolly, Stuart J.
    Spyropoulos, Alex
    Eikelboom, John
    Corbalan, Ramon
    Hu, Dayi
    Jansky, Petr
    Nielsen, Jorn Dalsgaard
    Ragy, Hany
    Raatikainen, Pekka
    Le Heuzey, Jean-Yves
    Darius, Harald
    Keltai, Matyas
    Kakkar, Sanjay
    Sawhney, Jitendra Pal Singh
    Agnelli, Giancarlo
    Ambrosio, Giuseppe
    Koretsune, Yukihiro
    Sanchez Diaz, Carlos Jerjes
    Ten Cate, Hugo
    Atar, Dan
    Stepinska, Janina
    Panchenko, Elizaveta
    Lim, Toon Wei
    Jacobson, Barry
    Oh, Seil
    Vinolas, Xavier
    Rosenqvist, Marten
    Steffel, Jan
    Angchaisuksiri, Pantep
    Oto, Ali
    Parkhomenko, Alex
    Al Mahmeed, Wael
    Fitzmaurice, David
    Hu, D. Y.
    Chen, K. N.
    Zhao, Y. S.
    Zhang, H. Q.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2018, 4 (01) : 27 - 35
  • [10] Impact of renal function on use of antithrombotic therapy in atrial fibrillation: real-world perspective from the global anticoagulant registry in the FIELD registry
    Goto, S.
    Lip, G. Y. H.
    Goldhaber, S. Z.
    Verheugt, F. W. A.
    Bassand, J. P.
    Turpie, A. G. G.
    Mueller, I.
    Rushton-Smith, S.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 967 - 968